Clinical value of SPP1 overexpression in patients with papillary thyroid carcinoma
Abstract Background: Secreted phosphoprotein 1 (SPP1) is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family. SPP1 is…
Abstract Background: Secreted phosphoprotein 1 (SPP1) is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family. SPP1 is…
Abstract Six transmembrane epithelial antigen of the prostate 1 (STEAP1) is a cell surface antigen for therapeutic targeting in prostate…
Abstract Background: The clinical outcomes are not always favorable in certain thyroid cancer patients. The effect of Forkhead-box family on…
Abstract Background: The efferocytosis-related molecules have been considered to be correlated with the resistance to cancer chemotherapy. The aim of…
Abstract Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is considered a novel anti-tumor target comparable to programmed cell death 1 ligand…
Abstract The current focus in the treatment of papillary thyroid carcinoma (PTC) is tumor progression. The aim of this study…
Abstract Gastric cancer (GC) was one of the most common types of the digestive system. COL8A1 was reported to be…
Abstract A growing emphasis in anticancer drug discovery efforts has been on targeting histone acetylation modulators. Here we comprehensively analyze…